Because Notch3-deficient mice exhibit modest vascular phenotypes but no serious defects51,52 and because NOTCH3 is not involved in NRF2-mediated cytoprotection, NOTCH3 inhibition is expected to exert anti-cancer effects without interfering with normal cellular functions in cancer-bearing hosts. Here, NFE2L2 is linked to cancer.